Ras oncogenes and p53 tumor suppressor gene analysis in cardiac myxomas

Pathology Research and Practice

Volumn 196, Issue 9, 2000, Pages 601-605

  Karga, Helen ^a   Papaioannou, Panayotis ^a   Karayianni, Maria ^a   Papadimitriou, Konstantina ^b   Priftis, Dimitris ^b   Voujuklakis, Theodore ^c   Migdou, Basiliki ^b   Nanas, john ^d   Papapetrou, Peter ^a  

^a ALEXANDRA HOSPITAL   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Myxomas; Oncogenes; p53; Ras

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DNA DETERMINATION; DNA SEQUENCE; EXON; GENE MUTATION; HEART MYXOMA; HETEROZYGOTE; HUMAN; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; ONCOGENE RAS; PATHOGENESIS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0033816623     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(00)80001-1     Document Type: Article

References (21)

1. The ras gene family and human carcinogenesis
2. Ras oncogenes in human cancer: A review
3. Cardiac myxoma: A clinicopathologic study
4. Cardiac myxomas: Immunohistochemical study of benign and malignant variants
5. Chromosomally abnormal clones and nonrandom telomeric translocations in cardiac myxomas
6. Cytogenetics of a case of cardiac myxoma
7. Familial atrial myxoma
8. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue
9. p53 Mutations in human cancers
10. Histogenesis of cardiac myxomas. An immunohistochemical study of cases, including one with glandular structures, and review of the literature
11. Detection of Ret proto-oncogene point mutations in paraffin embedded pheochromocytoma specimens by non radioactive single-strand conformation polymorphism analysis and direct sequencing
12. Cardiac myxomas. An immunohistochemical study using endothelial, histiocytic, and smooth-muscle cell markers
13. Primary cardiac tumors (forty years’ experience with 71 patients)
14. Cardiac myxomas
15. Cardiac myxoma characterized by clonal telomeric association
16. The pathology of metastatic cardiac myxoma
17. DNA analysis of cardiac myxomas: Flow cytometry and image analysis
18. Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney Complex)
19. The nature of the cardiac myxoma
20. ’Syndrome myxoma’: A subset of patients with cardiac myxomas associated with pigmented skin lesions and peripheral and endocrine neoplasms
21. Infrequent of ras, p53, WT1, or RB gene alterations in Wilms tumors